Interchange Capital Partners LLC Takes $214,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Interchange Capital Partners LLC acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,567 shares of the company’s stock, valued at approximately $214,000.

Other institutional investors also recently bought and sold shares of the company. ARK Investment Management LLC lifted its stake in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. NEA Management Company LLC lifted its position in Tempus AI by 17.8% in the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after buying an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. increased its position in shares of Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Tempus AI by 1.0% in the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after acquiring an additional 8,387 shares during the period. 24.22% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the transaction, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, major shareholder Bradley A. Keywell sold 170,720 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total value of $6,052,024.00. Following the completion of the sale, the insider now directly owns 15,993,729 shares of the company’s stock, valued at $566,977,693.05. The trade was a 1.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,598,969 shares of company stock worth $317,194,162 over the last ninety days.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $59.00 on Tuesday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm’s 50 day moving average price is $56.88 and its 200 day moving average price is $51.40. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on TEM shares. Needham & Company LLC increased their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, February 25th. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and lifted their price objective for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Loop Capital cut their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Bank of America raised their target price on Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Finally, William Blair reiterated a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Tempus AI has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.